COMP <GO>
HTFL vs MRK // FORWARD P/E MULTIPLE
Heartflow Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: HTFL 4
— MRK 9
▲ FORWARD P/E MULTIPLE LEADER: MRK
LAST: $59.05 (-2.45%) • MKT CAP: $5.26B
forward-pe
27.0x
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
forward-pe
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HTFL | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 76.80% | 74.80% | +2.00 | HTFL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.00% | 20.70% | -32.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.12% | 3.42% | -4.54 | MRK | /fcf-yield <GO> |
| Operating Margin | -36.40% | 34.30% | -70.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.10% | -88.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 39.90% | 1.30% | +38.60 | HTFL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.19 | +20.81 | HTFL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.3 | 56.9 | +10.45 | HTFL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.92 | -0.02 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 27.0x | 18.4x | +8.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.26B | $361.02B | -$355.76B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HTFL REV | MRK REV | HTFL GROSS % | MRK GROSS % | HTFL FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $176.0M | $65.01B | 76.8% | 74.8% | -$59.0M | $12.36B |
| FY 2024 | $125.8M | $64.17B | 75.1% | 76.3% | -$73.4M | $18.10B |
| FY 2023 | $87.2M | $60.12B | 44.0% | 44.0% | -$80.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
MRK // BETA 0.92